Literature DB >> 9439715

Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures.

K Yamaguchi1, R A Matulka, A M Shneider, P Toselli, A F Trombino, S Yang, L J Hafer, K K Mann, X J Tao, J L Tilly, R I Near, D H Sherr.   

Abstract

Numerous studies demonstrate that polycyclic aromatic hydrocarbons (PAH) suppress immunity by modifying the function of both B and T cells. Relatively few studies have assessed the effects of these common environmental chemicals on immature lymphocytes. In the present study, long-term primary bone marrow cultures were employed to investigate the effects of a prototypic PAH and aryl hydrocarbon receptor (AhR) agonist, 7,12-dimethylbenz[a]anthracene (DMBA), on immature B lymphocytes. In this system, immature preB cells are maintained in a supportive microenvironment provided by bone marrow stromal cells. Results presented here demonstrate that (1) exposure of primary bone marrow cultures to DMBA results in preB cell death by apoptosis; (2) notably low doses of DMBA (> or = 10(-8) M) induce preB cell apoptosis; (3) in long-term cultures, bone marrow stromal cells, but not preB cells, express AhR mRNA and protein as determined by in situ hybridization, RT-PCR, and immunoblotting; (4) freshly isolated unfractionated bone marrow cells, but not purified bone marrow B cells, express AhR protein as assessed by immunohistochemistry; (5) alpha-naphthoflavone, a competitive AhR inhibitor and cytochrome P450 antagonist, completely blocks DMBA-induced preB cell apoptosis in primary bone marrow cultures; and (6) DMBA or benzo[a]pyrene injection in vivo results in bone marrow cell apoptosis consistent with the death of hematopoietic cells clustered around stromal elements. The results implicate programmed cell death as a mechanism underlying DMBA-mediated immunosuppression and suggest that preB cell death is influenced by local interactions with AhR+ bone marrow stromal cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9439715     DOI: 10.1006/taap.1997.8263

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

1.  Proximal events in 7,12-dimethylbenz[a]anthracene-induced, stromal cell-dependent bone marrow B cell apoptosis: stromal cell-B cell communication and apoptosis signaling.

Authors:  Jessica E Teague; Heui-Young Ryu; Michael Kirber; David H Sherr; Jennifer J Schlezinger
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

Review 2.  Current understanding of the immunosuppressive properties of mesenchymal stromal cells.

Authors:  Ligia Lins de Castro; Miquéias Lopes-Pacheco; Daniel Jay Weiss; Fernanda Ferreira Cruz; Patricia Rieken Macêdo Rocco
Journal:  J Mol Med (Berl)       Date:  2019-03-22       Impact factor: 4.599

3.  From the Cover: Tributyltin Alters the Bone Marrow Microenvironment and Suppresses B Cell Development.

Authors:  Amelia H Baker; Ting Hua Wu; Alicia M Bolt; Louis C Gerstenfeld; Koren K Mann; Jennifer J Schlezinger
Journal:  Toxicol Sci       Date:  2017-07-01       Impact factor: 4.849

4.  The role of CaMKII in calcium-activated death pathways in bone marrow B cells.

Authors:  Stephanie L Bissonnette; Amelia Haas; Koren K Mann; Jennifer J Schlezinger
Journal:  Toxicol Sci       Date:  2010-09-01       Impact factor: 4.849

5.  Disruption of human plasma cell differentiation by an environmental polycyclic aromatic hydrocarbon: a mechanistic immunotoxicological study.

Authors:  Lenka L Allan; David H Sherr
Journal:  Environ Health       Date:  2010-03-24       Impact factor: 5.984

6.  Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A.

Authors:  Tessa J Murray; Xinhai Yang; David H Sherr
Journal:  Breast Cancer Res       Date:  2006-03-27       Impact factor: 6.466

7.  Aryl Hydrocarbon Receptor Contributes to the Transcriptional Program of IL-10-Producing Regulatory B Cells.

Authors:  Christopher J M Piper; Elizabeth C Rosser; Kristine Oleinika; Kiran Nistala; Thomas Krausgruber; André F Rendeiro; Aggelos Banos; Ignat Drozdov; Matteo Villa; Scott Thomson; Georgina Xanthou; Christoph Bock; Brigitta Stockinger; Claudia Mauri
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

8.  Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study.

Authors:  Brenda A Jensen; Rebecca J Leeman; Jennifer J Schlezinger; David H Sherr
Journal:  Environ Health       Date:  2003-12-16       Impact factor: 5.984

Review 9.  The role of the aryl hydrocarbon receptor in normal and malignant B cell development.

Authors:  David H Sherr; Stefano Monti
Journal:  Semin Immunopathol       Date:  2013-08-13       Impact factor: 9.623

Review 10.  Role of aryl hydrocarbon receptor in mesenchymal stromal cell activation: A minireview.

Authors:  Danilo Candido de Almeida; Laura Sibele Martins Evangelista; Niels Olsen Saraiva Câmara
Journal:  World J Stem Cells       Date:  2017-09-26       Impact factor: 5.326

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.